Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TUBB3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TUBB3 is a gene implicated in neurodegeneration research. Key relationships include: associated with, regulates, activates. Associated with ALS, Als, Alzheimer. Connected to 179 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TUBB3 |
| Full Name | TUBB3 (βIII-Tubulin) |
| Chromosome | 16q24.3 |
| Protein Family | Tubulin family |
| Protein Type | Structural Protein |
| Target Class | Structural Protein |
| Function | TUBB3 performs essential neuronal functions: |
| Mechanism of Action | Small molecule stabilizers of microtubule structure or assembly |
| Druggability | Medium (0.49) |
| Clinical Stage | Approved |
| Molecular Weight | 50 kDa |
| Amino Acids | 450 aa |
| Pathways | Akt, Autophagy, Cell Cycle, Pi3K, Proteasome |
| UniProt ID | G3V3R4 |
| Ensembl ID | ENSG00000198363 |
| GeneCards | TUBB3 |
| Human Protein Atlas | TUBB3 |
| Associated Diseases | Alzheimer, Alzheimer's disease, Bone Metastasis, Huntington, Huntington's disease, neurodegeneration |
| Known Drugs/Compounds | rapamycin |
| Interactions | ACTB, Actin, ALZHEIMER, ALZHEIMER DISEASE, APOPTOSIS, App |
| SciDEX Target | View Target Profile (8 clinical trials) |
| SciDEX Hypotheses | Quantum Coherence Disruption in Cellular Communica |
| KG Connections | 410 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
TUBB3["TUBB3
Neuronal Tubulin
Beta-3"]
%% Microtubule and Cytoskeleton
Microtubules["Microtubule
Assembly"]
Cytoskeleton["Neuronal
Cytoskeleton"]
%% Associated Proteins
HDAC6["HDAC6
Tubulin Deacetylase"]
VIM["VIM
Vimentin"]
SRC["SRC
Kinase"]
%% Autophagy Pathway
BECN1["BECN1
Beclin-1"]
MAP1LC3B["MAP1LC3B
LC3B"]
Autophagy["Autophagy
Process"]
%% Neurodegenerative Diseases
Alzheimer["Alzheimer's
Disease"]
Parkinson["Parkinson's
Disease"]
ALS["ALS
Motor Neuron Disease"]
Huntington["Huntington's
Disease"]
MS["Multiple
Sclerosis"]
%% Cellular Processes
Apoptosis["Neuronal
Apoptosis"]
Neurodegeneration["Neurodegeneration
Process"]
%% Connections
TUBB3 -->|"forms"| Microtubules
Microtubules -->|"maintains"| Cytoskeleton
HDAC6 -->|"deacetylates"| TUBB3
TUBB3 -->|"associates_with"| VIM
TUBB3 -->|"inhibits"| SRC
TUBB3 -->|"regulates"| BECN1
TUBB3 -->|"associates_with"| MAP1LC3B
BECN1 -->|"initiates"| Autophagy
MAP1LC3B -->|"mediates"| Autophagy
TUBB3 -->|"activates"| Alzheimer
TUBB3 -->|"regulates"| Parkinson
TUBB3 -->|"therapeutic_target"| ALS
TUBB3 -->|"associated_with"| Huntington
TUBB3 -->|"activates"| MS
TUBB3 -->|"therapeutic_target"| Apoptosis
TUBB3 -->|"activates"| Neurodegeneration
Cytoskeleton -->|"dysfunction_leads_to"| Neurodegeneration
Autophagy -->|"impairment_causes"| Neurodegeneration
%% Styling
style TUBB3 fill:#006494
style Autophagy fill:#1b5e20
style BECN1 fill:#1b5e20
style Alzheimer fill:#ef5350
style Parkinson fill:#ef5350
style ALS fill:#ef5350
style Huntington fill:#ef5350
style MS fill:#ef5350
style Neurodegeneration fill:#ef5350
style Apoptosis fill:#ef5350
style HDAC6 fill:#4a1a6b
style SRC fill:#4a1a6b
style Microtubules fill:#5d4400
style Cytoskeleton fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Anoikis Resistance | regulates | process | 0.95 |
| Anoikis Resistance | associated_with | process | 0.95 |
| Bone Metastatic Prostate Cancer | therapeutic_target | disease | 0.91 |
| Bone Metastasis | associated_with | phenotype | 0.90 |
| Parkinson'S Disease | associated_with | disease | 0.90 |
| Cell Migration | promotes | process | 0.90 |
| Cell Invasion | promotes | process | 0.90 |
| Apoptosis Resistance | promotes | process | 0.86 |
| Epithelial-Mesenchymal Transition | promotes | process | 0.85 |
| Prostate Cancer | biomarker_for | disease | 0.85 |
| Extracellular Matrix Detachment | modulates | process | 0.83 |
| Pca Cell Migration | inhibits | process | 0.80 |
| Pca Cell Invasion | inhibits | process | 0.80 |
| Parkinson's Disease | associated_with | disease | 0.80 |
| bone metastasis | suppresses | disease | 0.80 |
| Αvβ3/Fak/Src Axis | activates | signaling_pathway | 0.80 |
| anoikis resistance | suppresses | process | 0.80 |
| ITGAV | regulates | gene | 0.80 |
| Epithelial-Mesenchymal Transition (Emt) | regulates | process | 0.80 |
| oxidative stress response | participates_in | pathway | 0.80 |
| SRC | activates | gene | 0.75 |
| PTK2 | activates | gene | 0.75 |
| ITGAV | activates | gene | 0.75 |
| neural stem cells | activates | cell_type | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| Ms | regulates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Parkinson | regulates | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Prion | associated_with | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Prion Disease | associated_with | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| VIM | associated_with | gene | 0.60 |
| BECN1 | regulates | gene | 0.60 |
| HDAC6 | associated_with | gene | 0.60 |
| GAPDH | regulates | gene | 0.60 |
| MAP1LC3B | associated_with | gene | 0.60 |
| MAP3K5 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-4a31c1e0 | targets | hypothesis | 0.90 |
| RNA | expressed_in | gene | 0.60 |
| CTSB | expressed_in | gene | 0.60 |
| AR | activates | gene | 0.60 |
| CDC42 | activates | gene | 0.60 |
| SLC6A3 | interacts_with | gene | 0.60 |
| TUBB | interacts_with | gene | 0.60 |
| CTSB | activates | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| NF-KB | activates | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
| SYNAPSE | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | associated_with | gene | 0.60 |
| DMSO | activates | gene | 0.60 |
| HUNTINGTON | associated_with | gene | 0.60 |
| SYN1 | associated_with | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| ATG7 | activates | gene | 0.60 |
| MAP2 | associated_with | gene | 0.60 |
| TFEB | associated_with | gene | 0.60 |
| CTSD | associated_with | gene | 0.60 |
| CTSB | associated_with | gene | 0.60 |
| SNAP25 | associated_with | gene | 0.60 |
| SRC | activates | entity | 0.60 |
| HDAC6 | activates | entity | 0.60 |
| LAMP1 | activates | entity | 0.60 |
| MAP1LC3B | activates | entity | 0.60 |
| MAP3K5 | activates | entity | 0.60 |
| OCLN | activates | entity | 0.60 |
| P62 | activates | entity | 0.60 |
| PIK3C3 | activates | entity | 0.60 |
| RAC1 | activates | entity | 0.60 |
| SQSTM1 | activates | entity | 0.60 |
| STK11 | activates | entity | 0.60 |
| NDUFA9 | regulates | entity | 0.60 |
| SLC6A3 | regulates | entity | 0.60 |
| SNCA | regulates | entity | 0.60 |
| TUBB | regulates | entity | 0.60 |
| TUBULIN | associated_with | gene | 0.60 |
| GAP43 | expressed_in | gene | 0.60 |
| PSD95 | expressed_in | gene | 0.60 |
| SCIN | activates | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| LYSOSOME | regulates | gene | 0.60 |
| TJP1 | associated_with | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| UBIQUITIN | associated_with | gene | 0.60 |
| TJP1 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Quantum Coherence Disruption in Cellular Communication | 0.627 | neurodegeneration | Microglia-astrocyte crosstalk amplificat |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.729
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe | clinical | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $200,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Meta-analysis of mRNA dysregulation associated with Parkinson's disease and othe [PMID:41183391] | Lin Aung T, Aung YW, Shi X | Biomed Phys Eng Express | 2026 | 1 |
| Single-extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion [PMID:38868956] | Carlos J Nogueras-Ortiz, Erden Eren, Pam | Journal of extracellular vesic | 2024 | 1 |
| Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Ca [PMID:38809199] | Dong B, Gu Y, Sun X, Wang X, Zhou Y, Ron | Adv Healthc Mater | 2024 | 1 |
| Autophagy regulation and protein kinase activity of PIK3C3 controls sertoli cell [PMID:37450577] | Wang K, Kong F, Qiu Y, Chen T, Fu J, Jin | Autophagy | 2023 | 1 |
| Neuropathology of degenerative ataxias. [PMID:21827883] | Fratkin JD, Vig PJ | Handb Clin Neurol | 2012 | 1 |
| Tubulin mutations in human neurodevelopmental disorders. [PMID:35915025] | Maillard C, Roux CJ, Charbit-Henrion F, | Seminars in cell & development | 2023 | 0 |
| βIII-Tubulin Gene Regulation in Health and Disease. [PMID:35573698] | Duly AMP, Kao FCL, Teo WS, Kavallaris M | Frontiers in cell and developm | 2022 | 0 |
| BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the di [PMID:33404293] | Yazdankhah M, Ghosh S, Shang P, Stepiche | Autophagy | 2021 | 0 |
| Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradat [PMID:30983487] | Ho PW, Leung CT, Liu H, Pang SY, Lam CS, | Autophagy | 2020 | 0 |
| Cell signaling stabilizes morphogenesis against noise. [PMID:31628213] | ["Hagolani P", "Zimm R", "Marin-Riera M" | Development (Cambridge, Englan | 2019 | 0 |
| Benefits of improved air quality on ageing lungs: impacts of genetics and obesit [PMID:30765509] | ["H\u00fcls A", "Sugiri D", "Abramson M" | The European respiratory journ | 2019 | 0 |
| Educational Case: A Uterine Neoplasm: Leiomyoma-A Benign Neoplasm. [PMID:30116773] | ["Magid M"] | Academic pathology | 2018 | 0 |
| ICS teaching module: Ambulatory urodynamic monitoring. [PMID:26594872] | ["Digesu G", "Gargasole C", "Hendricken | Neurourology and urodynamics | 2017 | 0 |
| [ [PMID:28135241] | ["Zimmer E", "Parent M", "Souza D", "Leu | Nature neuroscience | 2017 | 0 |
| Toxins targeting voltage-activated Ca2+ channels and their potential biomedical [PMID:25714378] | ["Gandini M", "Sandoval A", "Felix R"] | Current topics in medicinal ch | 2015 | 0 |
| Integrative analysis reveals disease-associated genes and biomarkers for prostat [PMID:25080090] | ["Li Y", "Vongsangnak W", "Chen L", "She | BMC medical genomics | 2014 | 0 |
| Tau clearance mechanisms and their possible role in the pathogenesis of Alzheime [PMID:24027553] | ["Chesser A", "Pritchard S", "Johnson G" | Frontiers in neurology | 2013 | 0 |
| Extreme sarcoplasmic reticulum volume loss and compensatory T-tubule remodeling [PMID:22355118] | ["Swift F", "Franzini-Armstrong C", "\u0 | Proceedings of the National Ac | 2012 | 0 |
| The allometry of chronic myeloid leukemia. [PMID:19362566] | ["Pacheco J", "Traulsen A", "Dingli D"] | Journal of theoretical biology | 2009 | 0 |
| Evidence for wavelike energy transfer through quantum coherence in photosyntheti [PMID:17429397] | ["Engel G", "Calhoun T", "Read E", "Ahn | Nature | 2007 | 0 |
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning TUBB3 in their description or question text
No additional research found